Rating Change
JP Morgan reiterated its Neutral rating on Cardinal Health, Inc. (NYSE:CAH) on August 13, 2026.
JP Morgan reiterated its Neutral rating on Cardinal Health, Inc. (NYSE:CAH) on August 13, 2026.

At publication ·
Cardinal Health, Inc. (NYSE:CAH) · reiterate
At a glance
JP Morgan reiterated its Neutral rating on Cardinal Health, Inc. (NYSE:CAH) on August 13, 2026.
Cardinal Health, Inc. operates in the Healthcare sector. The stock currently trades at $231.24 with a market capitalization of $47.1B. The stock has gained 8.2% over the past 52 weeks.
Analyst coverage from JP Morgan provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Cardinal Health, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 13, 2026 | JP Morgan | Neutral | N/A |
| Aug 13, 2026 | TD Cowen | Buy | N/A |
| Aug 13, 2026 | Barclays | Overweight | N/A |
| Aug 12, 2026 | Morgan Stanley | Overweight | N/A |
| Aug 12, 2026 | Evercore ISI Group | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View CAH Stock Page
A rating of Neutral from JP Morgan reflects the analyst's outlook on Cardinal Health, Inc. (NYSE:CAH). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CAH forecast page.
Current market data
NYSE · CAH
Keep reading
analyst ·
analyst ·
analyst ·
analyst ·